Shoulder Innovations (SI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Apr, 2026Executive summary
Annual meeting scheduled for June 26, 2026, with voting available online or virtually.
Shareholders are encouraged to review proxy materials and vote by June 25, 2026.
Voting matters and shareholder proposals
Election of Class I directors, with Robert Ball and Andrew Hykes nominated.
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Board recommends voting in favor of all proposals.
Other business may be addressed if properly brought before the meeting.
Board of directors and corporate governance
Board recommends the election of two Class I director nominees.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Shoulder Innovations
- Innovative implants, AI planning, and outpatient focus drive rapid growth and market leadership.SI
Canaccord Genuity's 46th Annual Growth Conference - Registering $300M in securities and 8.1M shares for resale, targeting ASC-driven growth.SI
Registration filing - Q2 revenue up 56% YoY, guidance raised, and implant sales and innovation drive growth.SI
Q2 2026 - Director elections and auditor ratification approved; no stockholder questions submitted.SI
AGM 2026 - Innovative implants and AI-driven planning fuel rapid growth in the $2.8B shoulder arthroplasty market.SI
Investor presentation - Q1 2026 revenue surged 65% to $16.7M, with margin gains and a raised full-year outlook.SI
Q1 2026 - Annual meeting to elect directors and ratify auditor, with strong governance and risk oversight.SI
Proxy filing - Q4 revenue up 65% year-over-year; 2026 guidance targets 31–37% growth with strong margins.SI
Q4 2025 - Strong Q2 growth and innovative, efficient solutions drive momentum in the shoulder arthroplasty market.SI
Morgan Stanley 23rd Annual Global Healthcare Conference